VIRMA and colorectal cancer: KIAA1429 can promote aerobic glycolysis including increasing glucose uptake and lactate production by up-regulating HK2 (hexokinase 2, a crucial enzyme in aerobic glycolysis) expression in an m6A-dependent manner in colorectal cancer [33].